Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Neighbours

17 February 2012

Knowledge Transfer & Enterprise Champion Dr Michael Stewart (UCL Anthropology) talks about our inquisitiveness towards our neighbours, and MyStreetfilms, which aims to document social life all across Britain. Listen: BBC Radio 5 Live Breakfast (from 2hrs 53mins)